Orsero (ORS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
26 Nov, 2025Executive summary
Q1 2025 delivered strong growth with net sales up 12.6% to €379.6 million and adjusted EBITDA up 28% to €21.5 million, margin at 5.7%, driven by Distribution BU and improved product mix.
Adjusted EBIT increased 50.3% to €13.0 million; adjusted net profit rose 65.7% to €8.1 million; reported net profit was €7.5 million.
Growth was supported by higher volumes, favorable pricing, and strong performance in exotic fruits, bananas, and Plátano Canario, with resilience in France, Italy, and Mexico.
The business model's flexibility and logistics integration helped mitigate risks from tariffs and geopolitical uncertainty.
Dividend of €0.50/share (total €8.4 million) paid in May 2025; share buyback authorization renewed up to €10 million.
Financial highlights
Net sales reached €379.6 million (+12.3% YoY); Distribution BU contributed €40.2 million of the increase, Shipping BU €0.5 million.
Adjusted EBITDA margin improved to 5.7% from 5.0% prior year; Distribution BU margin at 4.4%, Shipping BU at 27.5%.
Net financial position at €115.1 million; cash and cash equivalents at €85.7 million.
Total equity increased to €260.7 million as of March 31, 2025.
Capex in Q1 2025 was €3.1 million, focused on warehouse improvements and ESG initiatives.
Outlook and guidance
FY 2025 guidance confirmed: Net sales €1,580–1,640 million, Adjusted EBITDA €77–82 million, Adjusted Net Profit €26–30 million, NFP €110–105 million.
Guidance will be reviewed quarterly, with potential for upgrade after summer campaigns.
ESG targets include full employee sustainability training and 100% food safety certification for warehouses.
Latest events from Orsero
- FY 2025 exceeded guidance with strong growth, margins, and a proposed €0.61 dividend.ORS
Q4 202513 Mar 2026 - Double-digit revenue and profit growth in H1 2025 led to an upward revision of FY guidance.ORS
Q2 20253 Feb 2026 - Net sales and EBITDA declined, but Q2 Distribution outperformed and cash flow stayed robust.ORS
H1 202420 Jan 2026 - Stable revenues and strong distribution offset profit decline; FY 2024 guidance confirmed.ORS
Q3 202413 Jan 2026 - 2024 targets met with resilient high-value growth and strong cash flow, despite margin pressure.ORS
Q4 202426 Dec 2025 - Strong revenue and profit growth in 9M 2025, with guidance confirmed at the upper end.ORS
Q3 202514 Nov 2025